Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

APGE US Equity

Apogee Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1974640 · FY ends Dec 31
$134.71
+0.14 (+0.10%)
USD · as of 2026-08-19 · marketstack
15 8-K filings · 4 13D · 10 13G
DateEventWhat happened / filerSource
2026-08-118-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-08-118-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLPsec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-06-2313D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Fairmount Funds Management LLCsec.gov ↗
2026-06-228-K 8.01Other eventssec.gov ↗
2026-06-228-K 7.01Regulation FD disclosuresec.gov ↗
2026-06-228-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-06-228-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-06-228-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-06-128-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-278-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-278-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-05-278-K 8.01Other eventssec.gov ↗
2026-05-278-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-248-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-04-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2026-03-2713D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Fairmount Funds Management LLCsec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-03-258-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-03-238-K 8.01Other eventssec.gov ↗
2026-03-238-K 7.01Regulation FD disclosuresec.gov ↗
2026-03-0613GSchedule 13G filed — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2026-03-028-K 9.01Financial statements and exhibitssec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by RTW INVESTMENTS, LPsec.gov ↗
2026-02-1013G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLPsec.gov ↗
2026-01-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-01-2313D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Fairmount Funds Management LLCsec.gov ↗
2026-01-068-K 8.01Other eventssec.gov ↗
2026-01-068-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by DRIEHAUS CAPITAL MANAGEMENT LLCsec.gov ↗
2025-11-108-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-1413D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Fairmount Funds Management LLCsec.gov ↗
2025-10-108-K 8.01Other eventssec.gov ↗
2025-10-108-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-10

Every row is a filed document, checked against its EDGAR index.